Pharmafit Provence
SENSIVISION AU PLANTAIN Collyre récip unidose 10unid
Back to products

SENSIVISION AU PLANTAIN Collyre récip unidose 10unid

VIDAL information
Your professional account

PharmaFit supplies pharmacies and healthcare professionals. Access your purchasing terms and availability through your professional account.

Access is reserved for authorised professionals, following account approval.

Contact PharmaFit

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
Update of 10/07/2025

*PLANTAIN SENSITIVISION®
plantain


Forms and presentations

Eye drops:  Single-dose containers of 0,4 ml, box of 10 (strips under sachet).


Composition

  single-dose p
Lanceolate plantain (soft leaf extract) 
8 mg
Excipients: boric acid, borax, disodium edetate, methyl parahydroxybenzoate, purified water.

Excipients with known effect: boric acid, borax and methyl parahydroxybenzoate.


Indications

Traditional herbal medicine used for eye irritation or discomfort due to various causes (smoky atmosphere, sustained visual strain, sea or swimming pool baths, etc.).
Its use is restricted to the specified indication exclusively on the basis of long-standing use.
Plantain Sensitivision, single-dose container eye drops, is indicated in adults.

Dosage and administration

Dosage

Adults:
Instil 1 or 2 drop(s) of eye drops into each eye, 2 to 4 times a day.
Paediatric population:
There is no justified use of Plantain Sensitivision, single-dose container eye drops in children and adolescents under the age of 18 years.

Method of administration:

Ophthalmic use.

  1. Wash hands thoroughly before instilling the eye drops.
  2. Avoid any contact of the single-dose container tip with fingers or the eye.
  3. Gently pull the lower eyelid downward while looking upward.
  4. Place one drop of eye drops in the space formed.
  5. Close the eye for a few seconds.
  6. With the eye closed, cleanly wipe away the excess.
  7. Press a finger on the corner of the eye on the side of the nose for 2 minutes. This will reduce the passage of the active ingredient (lanceolate plantain) into the rest of the body.
  8. Discard the single-dose container immediately after use.

Duration of treatment:

Treatment should not be extended beyond 2 days without medical advice.

If symptoms persist while using this medicine, a doctor or other qualified healthcare professional must be consulted.


Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section Composition.

Warnings and precautions

Do not use:

  • when the irritation is accompanied by pus (eyelids stuck together on waking in the morning),
  • in case of severe pain, direct impact, or injury. In these cases, consult a doctor.

Wearing contact lenses is not recommended while using the eye drops. Wait 30 minutes before putting the lens back in the eye.

Single-dose single-use container: do not reuse.

This medicine contains methyl parahydroxybenzoate, which may cause allergic reactions (possibly delayed).


Interactions

No interaction studies have been performed.


Fertility, pregnancy and breastfeeding

Pregnancy:

There are no teratogenicity data in animals. In clinical use, no particular malformative or fetotoxic effect has appeared to date. However, follow-up of exposed pregnancies is insufficient to rule out any risk. Consequently, as a precaution, use of this medicine is not recommended during pregnancy.


Breastfeeding:

Due to the absence of data on the passage of this medicine into breast milk, its use is not recommended during breastfeeding.

Fertility:

No data on fertility are available.



Adverse effects

Hypersensitivity or local irritation reactions, such as a burning sensation, stinging, or tearing, may occur after instillation.

Reporting of suspected adverse reactions:

Reporting of suspected adverse effects after registration of the medicine is important. It allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals report any suspected adverse effect via the national reporting system: the National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres. Website: www.signalement-sante.gouv.fr.


Pharmacodynamics

Pharmacotherapeutic class: Other ophthalmological medicines, ATC code: S01XA.


Preclinical safety

Non-clinical data from the ocular tolerance study conducted in rabbits (repeated administrations over 5 days of 4 daily instillations in 12 rabbits) showed good tolerance.

No carcinogenicity or reproductive toxicity studies have been performed.


Storage conditions

Shelf life
18 months.

Store below 25 °C.

Do not store after opening the container.


HANDLING/DISPOSAL INSTRUCTIONS

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.


Prescription, supply and reimbursement

Marketing authorisation (AMM) 3400934587160 (1999, SmPC rev 30.11.2020).
Not reimbursed by Social Security.


CHAUVIN Laboratory
416, rue Samuel-Morse. CS 99535. 34961 Montpellier
Tel: 04 67 12 30 30

Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.